Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06407934
Status:
RECRUITING
Last Update Posted:
2024-07-05
First Post:
2024-05-06
Brief Title:
A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Monotherapy Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis
Sponsor:
Sanofi
Organization:
Sanofi
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-08
Start Date Type:
ACTUAL
Primary Completion Date:
2026-06-23
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-01-05
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-06
First Submit QC Date:
May 6 2024
Study First Post Date:
2024-05-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-07
Last Update Post Date:
2024-07-05
Last Update Post Date Type:
ACTUAL